| Bioactivity | HCV-IN-31 (compound 4) is a HCV inhibitor, with an EC50/EC95 of 15.7 μM for HCV replicon[1]. |
| Target | EC50/EC95: 15.7 μM (HCV replicon). |
| Name | HCV-IN-31 |
| CAS | 1998705-62-6 |
| Formula | C12H17FN6O3 |
| Molar Mass | 312.30 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
| Reference | [1]. Jean-Pierre Sommadossi, et al. BETA-D-2-DEOXY-2-ALPHA-FLUORO-2- BETA-C-SUBSTITUTED-2-MODIFIED N6-SUBSTITUTED PURINE NUCLEOTDES FORHCV TREATMENT. US20160257706A1. |